AMN HEALTHCARE SERVICES INC (AMN) Fundamental Analysis & Valuation
NYSE:AMN • US0017441017
Current stock price
20.17 USD
-0.74 (-3.54%)
Last:
This AMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AMN Profitability Analysis
1.1 Basic Checks
- In the past year AMN was profitable.
- In the past year AMN had a positive cash flow from operations.
- In multiple years AMN reported negative net income over the last 5 years.
- AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of AMN (-4.57%) is worse than 67.00% of its industry peers.
- AMN has a worse Return On Equity (-14.90%) than 65.00% of its industry peers.
- The Return On Invested Capital of AMN (1.73%) is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for AMN is below the industry average of 8.51%.
- The 3 year average ROIC (6.19%) for AMN is well above the current ROIC(1.73%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -14.9% | ||
| ROIC | 1.73% |
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
1.3 Margins
- AMN has a Operating Margin of 1.21%. This is in the lower half of the industry: AMN underperforms 60.00% of its industry peers.
- In the last couple of years the Operating Margin of AMN has declined.
- AMN has a Gross Margin (28.35%) which is comparable to the rest of the industry.
- AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.21% | ||
| PM (TTM) | N/A | ||
| GM | 28.35% |
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
2. AMN Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMN is destroying value.
- AMN has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, AMN has less shares outstanding
- Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
- AMN has an Altman-Z score of 2.48. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
- AMN has a Altman-Z score (2.48) which is comparable to the rest of the industry.
- The Debt to FCF ratio of AMN is 3.28, which is a good value as it means it would take AMN, 3.28 years of fcf income to pay off all of its debts.
- AMN has a better Debt to FCF ratio (3.28) than 68.00% of its industry peers.
- AMN has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.
- AMN has a worse Debt to Equity ratio (1.19) than 65.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.19 | ||
| Debt/FCF | 3.28 | ||
| Altman-Z | 2.48 |
ROIC/WACC0.21
WACC8.16%
2.3 Liquidity
- A Current Ratio of 0.94 indicates that AMN may have some problems paying its short term obligations.
- AMN has a worse Current ratio (0.94) than 77.00% of its industry peers.
- A Quick Ratio of 0.94 indicates that AMN may have some problems paying its short term obligations.
- With a Quick ratio value of 0.94, AMN is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.94 |
3. AMN Growth Analysis
3.1 Past
- The earnings per share for AMN have decreased strongly by -58.91% in the last year.
- Measured over the past years, AMN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.94% on average per year.
- AMN shows a decrease in Revenue. In the last year, the revenue decreased by -8.49%.
- AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.67% yearly.
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
3.2 Future
- The Earnings Per Share is expected to grow by 52.37% on average over the next years. This is a very strong growth
- Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 7.67% on average per year.
EPS Next Y50.01%
EPS Next 2Y-8.09%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. AMN Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 14.83, which indicates a correct valuation of AMN.
- AMN's Price/Earnings ratio is rather cheap when compared to the industry. AMN is cheaper than 81.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.50, AMN is valued a bit cheaper.
- A Price/Forward Earnings ratio of 9.89 indicates a reasonable valuation of AMN.
- Based on the Price/Forward Earnings ratio, AMN is valued cheaply inside the industry as 89.00% of the companies are valued more expensively.
- AMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.62.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.83 | ||
| Fwd PE | 9.89 |
4.2 Price Multiples
- 80.00% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 97.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.33 | ||
| EV/EBITDA | 8.12 |
4.3 Compensation for Growth
- AMN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- AMN's earnings are expected to decrease with -7.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y-8.09%
EPS Next 3Y-7.38%
5. AMN Dividend Analysis
5.1 Amount
- AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMN Fundamentals: All Metrics, Ratios and Statistics
NYSE:AMN (4/23/2026, 3:49:08 PM)
20.17
-0.74 (-3.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19 2026-02-19/amc
Earnings (Next)05-07 2026-05-07/amc
Inst Owners104.07%
Inst Owner Change0.05%
Ins Owners0.38%
Ins Owner Change8.45%
Market Cap779.77M
Revenue(TTM)2.73B
Net Income(TTM)-95.70M
Analysts69.23
Price Target22.66 (12.35%)
Short Float %6.44%
Short Ratio1.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.78%
Min EPS beat(2)-21.51%
Max EPS beat(2)93.07%
EPS beat(4)3
Avg EPS beat(4)60.31%
Min EPS beat(4)-21.51%
Max EPS beat(4)116.02%
EPS beat(8)7
Avg EPS beat(8)40.9%
EPS beat(12)11
Avg EPS beat(12)30.43%
EPS beat(16)15
Avg EPS beat(16)25.36%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.64%
Max Revenue beat(2)2.36%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)2.36%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)7
Avg Revenue beat(12)0.85%
Revenue beat(16)11
Avg Revenue beat(16)1.44%
PT rev (1m)0%
PT rev (3m)8.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1232.99%
EPS NY rev (1m)9.78%
EPS NY rev (3m)164.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)94.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)24.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.83 | ||
| Fwd PE | 9.89 | ||
| P/S | 0.29 | ||
| P/FCF | 3.33 | ||
| P/OCF | 2.89 | ||
| P/B | 1.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.12 |
EPS(TTM)1.36
EY6.74%
EPS(NY)2.04
Fwd EY10.12%
FCF(TTM)6.05
FCFY29.99%
OCF(TTM)6.97
OCFY34.56%
SpS70.63
BVpS16.61
TBVpS-10.27
PEG (NY)0.3
PEG (5Y)N/A
Graham Number22.5441 (11.77%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -14.9% | ||
| ROCE | 2.19% | ||
| ROIC | 1.73% | ||
| ROICexc | 1.77% | ||
| ROICexgc | 5.91% | ||
| OM | 1.21% | ||
| PM (TTM) | N/A | ||
| GM | 28.35% | ||
| FCFM | 8.56% |
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
ROICexc(3y)6.27%
ROICexc(5y)13.02%
ROICexgc(3y)21.12%
ROICexgc(5y)45.11%
ROCE(3y)7.84%
ROCE(5y)15.78%
ROICexgc growth 3Y-59.99%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-59.19%
ROICexc growth 5Y-26.95%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
F-Score5
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.19 | ||
| Debt/FCF | 3.28 | ||
| Debt/EBITDA | 4.04 | ||
| Cap/Depr | 22.75% | ||
| Cap/Sales | 1.3% | ||
| Interest Coverage | 0.74 | ||
| Cash Conversion | 141.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | 2.48 |
F-Score5
WACC8.16%
ROIC/WACC0.21
Cap/Depr(3y)44.93%
Cap/Depr(5y)49.12%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
EPS Next Y50.01%
EPS Next 2Y-8.09%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%
EBIT growth 1Y-72.31%
EBIT growth 3Y-62.85%
EBIT growth 5Y-30.5%
EBIT Next Year231.17%
EBIT Next 3Y39.54%
EBIT Next 5YN/A
FCF growth 1Y-2.38%
FCF growth 3Y-25.82%
FCF growth 5Y1.44%
OCF growth 1Y-15.9%
OCF growth 3Y-25.58%
OCF growth 5Y0.97%
AMN HEALTHCARE SERVICES INC / AMN Fundamental Analysis FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?
ChartMill assigns a valuation rating of 7 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Undervalued.
Can you provide the profitability details for AMN HEALTHCARE SERVICES INC?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 3 / 10.
What are the PE and PB ratios of AMN HEALTHCARE SERVICES INC (AMN) stock?
The Price/Earnings (PE) ratio for AMN HEALTHCARE SERVICES INC (AMN) is 14.83 and the Price/Book (PB) ratio is 1.21.